Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients
暂无分享,去创建一个
[1] H. Noguchi,et al. Variable cross-reactivity of Pseudomonas aeruginosa lipopolysaccharide-code-specific monoclonal antibodies and its possible relationship with serotype. , 1992, Journal of general microbiology.
[2] A. Fomsgaard,et al. Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection , 1992, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[3] B A Dmitriev,et al. Structural characterization of the lipid A component of Pseudomonas aeruginosa wild-type and rough mutant lipopolysaccharides. , 1991, European journal of biochemistry.
[4] M. FitzGerald,et al. Bacteraemia and fungaemia in adults with cystic fibrosis. , 1991, Journal of Infection.
[5] V. Rosdahl,et al. Prevalence and persistence of polyagglutinable Pseudomonas aeruginosa in isolates from cystic fibrosis patients , 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[6] R. S. Conrad,et al. Structural studies of lipid A from Pseudomonas aeruginosa PAO1: occurrence of 4-amino-4-deoxyarabinose , 1990, Journal of bacteriology.
[7] C. Galanos,et al. Modification of the silver staining technique to detect lipopolysaccharide in polyacrylamide gels , 1990, Journal of clinical microbiology.
[8] A. Fomsgaard. Antibodies to lipopolysaccharides: Some diagnostic and protective aspects , 1990, APMIS. Supplementum.
[9] C. Galanos,et al. Quantitation and biological activities of native tumour necrosis factor from LPS‐stimulated human monocytes , 1990, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[10] R. Baltimore,et al. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. , 1989, The American review of respiratory disease.
[11] A. Cross,et al. The human antibody response during natural bacteremic infection with gram-negative bacilli against lipopolysaccharide core determinants. , 1989, The Journal of infectious diseases.
[12] C. Galanos,et al. Protective properties of a human IgG preparation rich in antibodies to a wide spectrum of lipopolysaccharides , 1989, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[13] K. Bendtzen,et al. Immunochemical and Biological Reactivity of Human Anti‐Lipopolysaccharide IgG Obtained by Screening of Blood Donors , 1989, Scandinavian journal of immunology.
[14] R. S. Conrad,et al. Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis , 1988, Infection and immunity.
[15] M. Brett,et al. Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: a follow-up study , 1988, Journal of clinical microbiology.
[16] E. Ziegler. Protective antibody to endotoxin core: the emperor's new clothes? , 1988, The Journal of infectious diseases.
[17] C. Galanos,et al. Large-scale fractionation of S-form lipopolysaccharide from Salmonella abortus equi. Chemical and serological characterization of the fractions. , 1988, Journal of chromatography.
[18] R. S. Conrad,et al. Comparative immunochemistry of lipopolysaccharides from typable and polyagglutinable Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis , 1988, Journal of clinical microbiology.
[19] N. Høiby,et al. Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme-linked immunosorbent assay , 1987, Journal of clinical microbiology.
[20] L. S. Young,et al. Human IgG antibodies to Pseudomonas aeruginosa core lipopolysaccharide determinants are detected in chronic but not acute pseudomonas infection. , 1987, Scandinavian journal of infectious diseases.
[21] T. Pitt,et al. Polyagglutinating and non-typable strains of Pseudomonas aeruginosa in cystic fibrosis. , 1986, Journal of medical microbiology.
[22] C. V. van Boven,et al. Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa , 1985, Infection and immunity.
[23] B. Appelmelk,et al. An enzyme-linked immunosorbent assay (ELISA) for the measurement of antibodies to different parts of the gram-negative lipopolysaccharide core region. , 1985, Journal of immunological methods.
[24] T. Pitt,et al. Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa , 1984, Infection and immunity.
[25] G. Pier,et al. Characterization of the human immune response to a polysaccharide vaccine from Pseudomonas aeruginosa. , 1983, The Journal of infectious diseases.
[26] P. Rowe,et al. Structure of the Core oligosaccharide from the lipopolysaccharide of Pseudomonas aeruginosa PAC1R and its defective mutants. , 1983, European journal of biochemistry.
[27] G. Pier,et al. Correlation of the biologic responses of C3H/HEJ mice to endotoxin with the chemical and structural properties of the lipopolysaccharides from Pseudomonas aeruginosa and Escherichia coli. , 1981, Journal of immunology.
[28] P. O. Schiøtz. Local humoral immunity and immune reactions in the lungs of patients with cystic fibrosis. , 1981, Acta pathologica et microbiologica Scandinavica. Supplement.
[29] E. Rietschel,et al. Interaction of lipopolysaccharides and lipid A with complement. , 1971, European journal of biochemistry.
[30] M Tuszkiewicz,et al. [Bacterial endotoxins]. , 1967, Polski tygodnik lekarski.
[31] O. Westphal. Bacterial lipopolysaccharides : extraction with phenol-water and further applications of the procedure , 1965 .
[32] J. Gustafson,et al. Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.